Skip to main content
    S

    STERIS plc (STE)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NYSE

    $257.35
    -4.56 (-1.74%)

    Market Cap: $25.43B

    Last updated: Nov 17, 2026 at 4:20 PM ET

    STERIS plc (STE) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    STERIS (STE) has a market cap of $25.43B and an enterprise value of $26.91B. Its trailing P/E is 23.6x.

    Total Valuation

    Enterprise value is 5.82% above the market cap, as debt exceeds cash.

    Market Cap$25.43B
    Enterprise Value$26.91B
    Latest price (Nov 17, 2026)$257.35

    Key Dates

    The next earnings report is expected on Feb 2, 2027, covering the quarter ending Dec 31, 2026. The last ex-dividend date was Nov 17, 2026.

    Next Earnings DateFeb 2, 2027 (expected)
    Last Earnings DateNov 4, 2026
    Last Ex-Dividend DateNov 17, 2026
    Next Payment DateDec 17, 2026
    Fiscal Year EndMarch

    Share Statistics

    The share count fell 0.40% in the quarter ended Sep 30, 2026 and shrank 0.81% a year over 2 years.

    Shares Outstanding97.11M
    Shares Change (YoY)-1.06%
    Shares Change (QoQ)-0.40%
    Share Count Growth (2Y CAGR)-0.81%

    Valuation Ratios

    Sales and book value multiples are 4.1x and 3.4x. Its year-end P/E ranged from 18.9x to 32.5x from 2016 to 2025.

    P/E Ratio23.6x
    Forward P/E22.4x
    P/S Ratio4.1x
    Forward P/S4.0x
    P/B Ratio3.4x
    P/TBV Ratio15.8x
    P/FCF Ratio26.7x
    P/OCF Ratio19.7x
    PEG Ratio2.8

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 15.8x EBITDA and 28.2x free cash flow.

    EV / Earnings32.4x
    EV / Sales4.4x
    EV / EBITDA15.8x
    EV / EBIT22.8x
    EV / FCF28.2x

    Price Statistics

    The stock is up 0.09% over 52 weeks and trades 14.48% above its 50-day average.

    Beta (1Y)0.40
    52-Week Change+0.09%
    1-Month Change+15.94%
    3-Month Change+8.96%
    6-Month Change+20.75%
    5-Year Change-2.83%
    10-Year Change+239.90%
    Total Return (1Y)+1.36%
    Total Return (3Y CAGR)+9.53%
    Total Return (5Y CAGR)+2.74%
    Return vs SPY (1Y)-11.17%
    Max Drawdown (1Y)-25.59%
    Max Drawdown (3Y)-25.59%
    Sharpe Ratio (1Y)0.01
    Correlation with SPY (1Y)0.21
    50-Day Average$224.80
    200-Day Average$223.45
    52-Week Range$193.46 to $266.68
    RSI (14 Days)66.2
    Average Volume (20 Days)903.72K

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 2.05x current liabilities, and total debt is 0.28x shareholder equity.

    Current Ratio2.05x
    Quick Ratio1.44x
    Debt / Equity0.28x
    Debt / EBITDA1.20x
    Debt / FCF2.15x
    Interest Coverage20.75x

    Returns and Efficiency

    Return on invested capital is 9.40% over the last 12 months, against a 5-year average of 6.91%.

    Return on Equity (ROE)11.43%
    Return on Assets (ROA)7.74%
    Return on Invested Capital (ROIC)9.40%
    Return on Capital Employed (ROCE)12.42%
    ROE (5Y Average)6.35%
    ROA (5Y Average)3.98%
    ROIC (5Y Average)6.91%
    Asset Turnover0.58x
    Inventory Turnover4.72x
    Receivables Turnover6.11x
    Cash Conversion Cycle101 days

    Taxes

    Income tax took 26.17% of pretax income over the last 12 months.

    Income Tax (TTM)$294.10M
    Effective Tax Rate26.17%

    Scores

    STE has an Altman Z-Score of 5.87, in the safe zone above 2.99, and a Piotroski F-Score of 9 of 9, in the strong band of 8 or 9.

    Altman Z-Score5.87
    Altman Z ZoneSafe
    Piotroski F-Score9 of 9
    Piotroski StrengthStrong

    Income Statement

    Revenue of $6.17B over the last 12 months is up 8.12% from the 12 months before.

    Revenue$6.17B
    Revenue Growth (YoY)+8.12%
    Gross Profit$2.75B
    Operating Income$1.17B
    Pretax Income$1.12B
    Net Income$829.70M
    EBITDA$1.68B
    EBIT$1.18B
    Reported EPS (TTM)$10.89

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 67.79% of the $10.71B in total assets.

    Cash and Equivalents$531.10M
    Total Debt$2.01B
    Net Debt$1.48B
    Net Debt Per Share$15.25
    Working Capital$1.27B
    Shareholder Equity$7.26B
    Book Value Per Share$74.74
    Tangible Book Value$1.58B
    Tangible Book Per Share$16.29
    Total Assets$10.71B
    Total Liabilities$3.44B

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $352.50M of capital spending, operating cash flow left $937.20M of free cash flow.

    Operating Cash Flow$1.29B
    Capital Expenditures$352.50M
    Free Cash Flow$937.20M
    FCF Per Share$9.61
    Depreciation and Amortization$494.80M
    Dividends Paid$254.40M
    Share Repurchases$340.30M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is 18.98%, against a 5-year average of 15.89%.

    Gross Margin44.56%
    Operating Margin18.98%
    Pretax Margin18.23%
    Net Margin13.46%
    EBITDA Margin27.17%
    EBIT Margin19.15%
    FCF Margin15.20%
    Gross Margin (5Y Average)43.93%
    Operating Margin (5Y Average)15.89%
    Net Margin (5Y Average)8.00%

    Growth

    Revenue grew 9.38% a year over 3 years, and EPS 7.40% a year.

    Revenue Growth (3Y CAGR)+9.38%
    Revenue Growth (5Y CAGR)+13.82%
    EPS Growth (3Y CAGR)+7.40%
    EPS Growth (5Y CAGR)+10.58%
    FCF Growth (3Y CAGR)+35.03%
    FCF Growth (5Y CAGR)+16.64%
    Operating Income Growth (3Y CAGR)+11.68%
    Book Value Per Share Growth (2Y CAGR)+7.01%
    Tangible Book Per Share Growth (2Y CAGR)+250.14%

    Revenue and profit by year

    Dividends and Yields

    STE pays out 24.62% of earnings as dividends.

    Dividend Per Share (Annual)$2.76
    Dividend Yield1.07%
    Payment ScheduleQuarterly
    Dividend Growth (3Y CAGR)+10.06%
    Dividend Growth (5Y CAGR)+9.28%
    Payout Ratio24.62%
    FCF Payout Ratio27.14%
    Earnings Yield4.24%
    FCF Yield3.75%
    Buyback Yield1.36%
    Shareholder Yield2.38%

    Full dividend history

    Peer Position

    Against 9 similar companies, STE has the 4th highest P/E.

    P/E Ratio23.6x vs 22.0x median
    P/S Ratio4.1x vs 3.0x median
    ROIC9.40% vs 10.80% median
    Revenue Growth (Trailing 4 Quarters, YoY)+8.12% vs +7.43% median
    Dividend Yield1.07% vs 0.20% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 7.31% and EPS growth at 10.67% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+7.31%
    EPS Growth Forecast (2Y CAGR)+10.67%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About STE

    What is STE's market cap?

    STERIS has a market cap of $25.43B. Its enterprise value, which adds debt and subtracts cash, is $26.91B.

    What is STE's P/E ratio?

    STERIS has a trailing P/E ratio of 23.6x and a forward P/E of 22.4x.

    How many shares of STE are outstanding?

    STERIS has 97.11M shares outstanding. The count is down 1.06% from a year earlier.

    Does STE pay a dividend?

    Yes. STERIS pays $2.76 a share a year, a dividend yield of 1.07%.

    How much debt does STE have?

    STERIS has $2.01B of total debt and $531.10M of cash and equivalents, a net debt position of $1.48B.